Correction: Type I Interferon: Potential Therapeutic Target for Psoriasis?

Correction: Type I Interferon: Potential Therapeutic Target for Psoriasis?

Bibliographic Details
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2009-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2665006/?tool=EBI

Similar Items

Endothelial type I interferon response and brain diseases: identifying STING as a therapeutic target
by: Nádia Duarte, et al.
Published: (2023-09-01)

Genetic analysis of potential biomarkers and therapeutic targets in ferroptosis from psoriasis
by: Man-Ning Wu, et al.
Published: (2023-01-01)

Targeting type I interferons in systemic lupus erythematous
by: Sebastian Bruera, et al.
Published: (2023-01-01)

Correction: Signaling pathways and targeted therapies for psoriasis
by: Jia Guo, et al.
Published: (2024-01-01)

I15 Targeting type I interferon in SLE and lupus nephritis
by: Richard Furie
Published: (2024-03-01)

Type I Interferon Pathway-Related Hub Genes as a Potential Therapeutic Target for SARS-CoV-2 Omicron Variant-Induced Symptoms
by: Zhiwei Lin, et al.
Published: (2023-08-01)

The role of plasmacytoid dendritic cells and interferon-alpha in the immunopathogenesis of psoriasis
by: Rafael Denadai
Published: (2013-01-01)

ZNF384: A Potential Therapeutic Target for Psoriasis and Alzheimer’s Disease Through Inflammation and Metabolism
by: Shougang Liu, et al.
Published: (2022-05-01)

Enterovirus D68 VP3 Targets the Interferon Regulatory Factor 7 To Inhibit Type I Interferon Response
by: Jun Kang, et al.
Published: (2023-06-01)

STAT and Janus kinase targeting by human herpesvirus 8 interferon regulatory factor in the suppression of type-I interferon signaling.
by: Qiwang Xiang, et al.
Published: (2022-07-01)

TRIM28 facilitates type I interferon activation by targeting TBK1
by: Fang Hua, et al.
Published: (2024-03-01)

Harnessing type I interferon-mediated immunity to target malignant brain tumors
by: Juhee Lim, et al.
Published: (2023-05-01)

The paeonol target gene autophagy-related 5 has a potential therapeutic value in psoriasis treatment
by: Qian Zhang, et al.
Published: (2021-05-01)

Signaling Pathways of Type I and Type III Interferons and Targeted Therapies in Systemic Lupus Erythematosus
by: I-Tsu Chyuan, et al.
Published: (2019-08-01)

Interferons lambda – therapeutic application
by: N. A. Kikhtenko, et al.
Published: (2020-05-01)

401 Type I interferon in NPSLE
Published: (2022-12-01)

Immune cells in the epithelial immune microenvironment of psoriasis: emerging therapeutic targets
by: Lisha Li, et al.
Published: (2024-01-01)

S100 Proteins as Novel Therapeutic Targets in Psoriasis and Other Autoimmune Diseases
by: Katarzyna Kurpet, et al.
Published: (2022-10-01)

A prediction model identifying glycolysis signature as therapeutic target for psoriasis
by: Yanhong Shou, et al.
Published: (2023-05-01)

Therapeutically targeting type I interferon directly to XCR1+ dendritic cells reveals the role of cDC1s in anti-drug antibodies
by: Paul Noe, et al.
Published: (2023-10-01)

Inhibition of urothelial carcinoma through targeted type I interferon-mediated immune activation
by: Devin Plote, et al.
Published: (2019-05-01)

Stimulator of interferon genes (STING): Key therapeutic targets in ischemia/reperfusion injury
by: Juan Lv, et al.
Published: (2023-11-01)

Evidence and suggested therapeutic approach in psoriasis of difficult-to-treat areas: Palmoplantar psoriasis, nail psoriasis, scalp psoriasis, and intertriginous psoriasis
by: Nilendu Sarma
Published: (2017-01-01)

Targeting type I interferon (IFN) signalling in patients with RA with a high type I IFN gene signature
by: Josef S Smolen, et al.
Published: (2022-11-01)

Phosphorylation Of Human Interferon Regulatory Factor 9 During Type I Interferon Response
by: Anak Paul Joko, Alvin Dickson
Published: (2021)

Keratinocyte-derived circulating microRNAs in extracellular vesicles: a novel biomarker of psoriasis severity and potential therapeutic target
by: Young Joon Park, et al.
Published: (2024-03-01)

Type I Interferons in COVID-19 Pathogenesis
by: Enrico Palermo, et al.
Published: (2021-08-01)

Stochastic dynamics of Type-I interferon responses.
by: Benjamin D Maier, et al.
Published: (2022-10-01)

Type-I Interferon Signaling in Fanconi Anemia
by: Karima Landelouci, et al.
Published: (2022-02-01)

Role of Type I Interferons on Filovirus Pathogenesis
by: Beatriz Escudero-Pérez, et al.
Published: (2019-02-01)

Correction to: Transcriptomes of microglia in experimental cerebral malaria in mice in the presence and absence of Type I Interferon signaling
by: Carlos Talavera-López, et al.
Published: (2019-01-01)

Enhanced serum interferon-lambda 1/interleukin-29 levels in patients with psoriasis vulgaris
by: Li-xin Fu, et al.
Published: (2021-08-01)

Chicken anemia virus VP1 negatively regulates type I interferon via targeting interferon regulatory factor 7 of the DNA-sensing pathway
by: Xuelan Liu, et al.
Published: (2023-01-01)

Pathogenicity of Type I Interferons in <i>Mycobacterium tuberculosis</i>
by: Akaash Mundra, et al.
Published: (2023-02-01)

Pathogenic sphingosine 1-phosphate pathway in psoriasis: a critical review of its pathogenic significance and potential as a therapeutic target
by: Yuechun Zhao, et al.
Published: (2023-04-01)

Sandfly Fever Viruses Attenuate the Type I Interferon Response by Targeting the Phosphorylation of JAK-STAT Components
by: Yarden Moalem, et al.
Published: (2022-06-01)

Proteotranscriptomic analyses reveal distinct interferon-beta signaling pathways and therapeutic targets in choroidal neovascularization
by: Yuxiang Hu, et al.
Published: (2023-03-01)

The role of type I interferons in regulating intestinal inflammation
by: Kole, A
Published: (2013)

LncRNAs in the Type I Interferon Antiviral Response
by: Beatriz Suarez, et al.
Published: (2020-09-01)

Type I Interferons, Autophagy and Host Metabolism in Leprosy
by: Thiago Gomes Toledo Pinto, et al.
Published: (2018-04-01)